title: Rituximab as salvage therapy for refractory chronic GVHD.
authors.forename: M
authors.initials: M
authors.lastname: Mohty
authors.forename: N
authors.initials: N
authors.lastname: Marchetti
authors.forename: J
authors.initials: J
authors.lastname: El-Cheikh
authors.forename: C
authors.initials: C
authors.lastname: Faucher
authors.forename: S
authors.initials: S
authors.lastname: Fürst
authors.forename: D
authors.initials: D
authors.lastname: Blaise
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D002908:Chronic Disease; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy*; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D000069283:Rituximab; D016879:Salvage Therapy / Q000379:methods*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab